title: [Role of C-reactive protein in the diagnosis, prognosis and follow-up of community-acquired pneumonia].
abstract: Community-acquired pneumonia (CAP) is a major clinical problem in terms of morbidity, mortality, and use of hospital resources. It is well recognized that a delay in making the diagnosis and instituting appropriate antibiotic treatment is associated with an increased mortality. C-reactive protein may be helpful in the management of patients with CAP. CRP is widely used in the management of CAP, including diagnosis, prognosis and follow-up. But its usefulness is not known. The aim of this systematic review was to evaluate the usefulness of CRP in the diagnosis, prognosis and follow-up of CAP.
authors.affiliation: Service de médecine interne, Département de médecine, CHUV, 1011 Lausanne.
authors.forename: Sophie
authors.initials: S
authors.lastname: Bauer
authors.forename: Olivier
authors.initials: O
authors.lastname: Lamy
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D017714:Community-Acquired Infections / Q000097:blood / Q000175:diagnosis; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D018410:Pneumonia, Bacterial / Q000097:blood* / Q000175:diagnosis*; D011379:Prognosis; D012720:Severity of Illness Index
chemical_list: D000900:Anti-Bacterial Agents; D015415:Biomarkers; D002097:C-Reactive Protein